Limited-efficacy Testing of SDS and NEMOST for Early Onset Neuromuscular Scoliosis
BiPOWR
Limited-efficacy Testing of Spring Distraction System (SDS) and a Bilateral One Way Rod (NEMOST) for Early Onset Neuromuscular Scoliosis (BiPOWR)
1 other identifier
interventional
28
1 country
3
Brief Summary
The primary aim of this study is to investigate and describe the limited efficacy of the Spring Distraction System (SDS) and Bilateral One Way Rod (NEMOST) in maintaining curve reduction without repeat lengthening procedures and complications. Secondary aims are to describe growth of the instrumented spine, health-related quality of life, and to compare both devices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2019
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 6, 2019
CompletedFirst Submitted
Initial submission to the registry
June 13, 2019
CompletedFirst Posted
Study publicly available on registry
July 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2023
CompletedJune 5, 2023
June 1, 2023
3.9 years
June 13, 2019
June 1, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Limited-efficacy of SDS and NEMOST in terms of curve correction maintenance
Changes in cobb angle on radiographs post-op and at 4 weeks, 3 months, 6 months and 12 months follow-up (FU). A maximum of 5 degrees increase will be the threshold to define maintenance.
Until 1 year post-operatively
Incidence of possible Treatment-Emergent Serious Adverse Events of SDS and NEMOST
Reported treatment related Serious Adverse Events (SAEs) per-operatively and at 4 weeks, 3 months, 6 months and 12 months FU.
Until 1 year post-operatively
Secondary Outcomes (12)
Limited-efficacy of SDS and NEMOST in terms of spinal length
Until 1 year post-operatively
SDS vs. NEMOST with respect to limited-efficacy in terms of curve correction maintenance
Until 1 year post-operatively
SDS vs. NEMOST with respect to limited-efficacy in terms of spinal length
Until 1 year post-operatively
SDS vs. NEMOST with respect to the development of the sagittale profile and instrumented thoracic kyphosis
Until 1 year post-operatively
SDS vs. NEMOST with respect to surgery time
Until 1 year post-operatively
- +7 more secondary outcomes
Study Arms (2)
Spring Distraction System (SDS)
EXPERIMENTALThe SDS will be placed and fits around a standard rod of 5.5mm.
Necker Enfants Malade OSTeosynthesis (NEMOST)
EXPERIMENTALThe NEMOST is a one-way-rod that uses a ratchet type of locking mechanism. Both NEMOST devices should be placed in parallel, on the two fixator rods that are connected with a cross connector
Interventions
Eligibility Criteria
You may qualify if:
- Non ambulant
- Neuromuscular or syndromal scoliosis
- Progressive scoliosis indicated for bipolar fixation extending to the pelvis
- Diagnosis of scoliosis before age 10
- Patient under 12 and open triradiate cartilage (usually closes around 12 years for girls and 14 years for boys)
- Main curve proximal end vertebra below Th 3
- Non rigid curve
- Patients who have an indication for a primary surgery
You may not qualify if:
- Ambulant
- Patients with closed triradiate cartilage
- Patients with a skeletal dysplasia that effects growth (Achondroplasia, SED)
- Patients with a systemic disease which severely influences bone quality e.g. osteogenesis imperfecta, metabolic diseases
- Patients with soft tissue weakness (Ehler Danlos, Marfan, Neurofibromatosis, Prader Willi)
- Patients that have a congenital anomaly of the spine of more than 5 vertebrae
- Patients with an active systemic disease such as JIA, HIV, oncologic treatment
- Patients with a previous surgical fusion of the spine
- Patients that are expected to be lost to FU due to e.g. likely to immigrate within 1 year.
- Patients that have had a previous spine surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UMC Utrechtlead
- EUROScollaborator
Study Sites (3)
Amsterdam UMC
Amsterdam, North Holland, 1105AZ, Netherlands
Erasmus Medical Center
Rotterdam, Netherlands
UMC Utrecht
Utrecht, 3584CX, Netherlands
Related Publications (1)
Lemans JVC, Tabeling CS, Scholten EP, Stempels HW, Miladi L, Castelein RM, Kruyt MC. Surgical treatment of neuromuscular Early Onset Scoliosis with a bilateral posterior one-way rod compared to the Spring Distraction System: study protocol for a limited-efficacy Randomized Controlled Trial (BiPOWR). BMC Musculoskelet Disord. 2023 Jan 10;24(1):20. doi: 10.1186/s12891-022-06048-4.
PMID: 36627616DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Moyo C Kruyt, MD, PhD
UMC Utrecht
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The patient is blinded to the medical device until after surgery. This is done to prevent selection bias through withdrawal. Patients are unblinded post-operatively, to enable accurate patient counseling with radiographs, on which the implant can be clearly seen.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Orthopaedic surgeon
Study Record Dates
First Submitted
June 13, 2019
First Posted
July 16, 2019
Study Start
May 6, 2019
Primary Completion
March 13, 2023
Study Completion
March 13, 2023
Last Updated
June 5, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share